The obtained results are consistent with the latest literature data, even though available data regarding the effects of alpha-lipoic acid (ALA) supplementation on inflammatory markers are controversial, the recent meta-analysis showed the promising impact of ALA administration on decreasing inflammatory markers, such as CRP, IL-6 and TNF-α among patients with metabolic disorders [32]. This evidence concerns the gene IL6 and metabolic disease.